Ex vivo infection of murine precision-cut lung tissue slices with Mycobacterium abscessus: a model to study antimycobacterial agents.

Annals of Clinical Microbiology and Antimicrobials
Carmen Amelia Molina-TorresPilar Carranza-Rosales

Abstract

Multidrug-resistant infections due to Mycobacterium abscessus often require complex and prolonged regimens for treatment. Here, we report the evaluation of a new ex vivo antimicrobial susceptibility testing model using organotypic cultures of murine precision-cut lung slices, an experimental model in which metabolic activity, and all the usual cell types of the organ are found while the tissue architecture and the interactions between the different cells are maintained. Precision cut lung slices (PCLS) were prepared from the lungs of wild type BALB/c mice using the Krumdieck® tissue slicer. Lung tissue slices were ex vivo infected with the virulent M. abscessus strain L948. Then, we tested the antimicrobial activity of two drugs: imipenem (4, 16 and 64 μg/mL) and tigecycline (0.25, 1 and 4 μg/mL), at 12, 24 and 48 h. Afterwards, CFUs were determined plating on blood agar to measure the surviving intracellular bacteria. The viability of PCLS was assessed by Alamar Blue assay and corroborated using histopathological analysis. PCLS were successfully infected with a virulent strain of M. abscessus as demonstrated by CFUs and detailed histopathological analysis. The time-course infection, including tissue damage, parallels in vivo f...Continue Reading

References

Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·A R CullenA A Colin
Oct 5, 2002·Clinical Microbiology Reviews·Barbara A Brown-Elliott, Richard J Wallace
Dec 22, 2006·Nature·Jim Giles
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Mar 4, 2008·Journal of Leukocyte Biology·Diane OrdwayEdward D Chan
Aug 8, 2009·American Journal of Respiratory and Critical Care Medicine·Kyeongman JeonWon-Jung Koh
May 6, 2010·Archives of Pathology & Laboratory Medicine·Sanjay Mukhopadhyay, Anthony A Gal
Feb 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julie JarandCharles L Daley
Feb 1, 2012·The Journal of Antimicrobial Chemotherapy·Rachid NessarBrigitte Gicquel
Mar 24, 2012·The European Respiratory Journal·Kolja V SzymanskiAndreas C Hocke
Oct 30, 2013·Infection and Immunity·Jens JägerMichael Steinert
Nov 14, 2013·The Journal of Antimicrobial Chemotherapy·Mary Ann De GrooteMercedes Gonzalez-Juarrero
Nov 21, 2013·The Journal of Infectious Diseases·Isabelle LeratNicolas Veziris
Jan 31, 2014·Infection and Immunity·Olivier Neyrolles
Feb 28, 2014·Journal of Oral and Maxillofacial Pathology : JOMFP·S Nalin KumarJ Muruganandhan
Jul 31, 2014·Archives of Pathology & Laboratory Medicine·John Fowler, Steven D Mahlen
Feb 13, 2015·PloS One·Lindsay J CaverlyDavid P Nichols
Apr 1, 2015·European Journal of Pharmacology·Melanie L Graham, Mark J Prescott
Apr 19, 2015·Retrovirology·Chris CousensDavid J Griffiths
Jul 28, 2015·Annals of the American Thoracic Society·Sara E StrolloD Rebecca Prevots
Aug 4, 2015·Dermatology Reports·Wai Sze Agnes ChanJiun Yit Pan
Aug 26, 2015·Antimicrobial Agents and Chemotherapy·Andrés Obregón-HenaoDiane J Ordway
Feb 24, 2016·Infection and Immunity·Joseph G GrahamDaniel E Voth
Mar 2, 2016·Antimicrobial Agents and Chemotherapy·Beatriz E FerroTawanda Gumbo
Mar 2, 2016·The Journal of Antimicrobial Chemotherapy·Anne-Laure LefebvreJean-Luc Mainardi
Nov 17, 2016·International Journal of Mycobacteriology·Pankaj Garg
Dec 9, 2016·Human Vaccines & Immunotherapeutics·Angela TemannVidadi Yusibov
Dec 25, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Won-Jung KohO Jung Kwon
Oct 21, 2017·Tuberculosis·Pilar Carranza-RosalesJorge Castro-Garza

❮ Previous
Next ❯

Citations

Sep 28, 2021·Molecular Microbiology·Flávia VianaGunnar N Schroeder

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

The Canadian Journal of Hospital Pharmacy
Pan Pan WangFanny Arbour
International Journal of Molecular Sciences
Michal Meir, Daniel Barkan
© 2021 Meta ULC. All rights reserved